Inflammation influences vascular remodeling through AT2 receptor expression and signaling

Physiological Genomics

Volumn 2000, Issue 2, 2000, Pages 13-20

  Akishita, Masahiro ^a   Horiuchi, Masatsugu ^a   Yamada, Hiroyuki ^a   Zhang, Lunan ^a   Shirakami, Gotaro ^a   Tamura, Kouichi ^a   Ouchi, Yasuyoshi ^b   Dzau, Victor J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiotensin; Apoptosis; Artery; Proliferation; Smooth muscle

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; CYTOKINE; DNA BINDING PROTEIN; GAMMA INTERFERON; IMIDAZOLE DERIVATIVE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1; INTERLEUKIN 6; IRF1 PROTEIN, MOUSE; MESSENGER RNA; PHOSPHOPROTEIN; PYRIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FEMORAL ARTERY; GENE EXPRESSION REGULATION; GENETICS; HEART RATE; HEMODYNAMICS; INFLAMMATION; INTIMA; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUNICA MEDIA;

ANIMALS; BLOOD PRESSURE; CYTOKINES; DNA-BINDING PROTEINS; FEMALE; FEMORAL ARTERY; GENE EXPRESSION REGULATION; HEART RATE; HEMODYNAMIC PROCESSES; IMIDAZOLES; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA;

EID: 0034707501     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.2000.2.1.13     Document Type: Article

References (44)

1. Akishita, M., Y. Ouchi, H. Miyoshi, K. Kozaki, S. Inoue, M. Ishikawa, M. Eto, K. Toba, and H. Orimo. Estrogen inhibits cuff-induced intimai thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 130:1-10, 1997.
2. Booz, G. W., and K. M. Baker. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28: 635-640, 1996.
3. Dimmeler, S., V. Rippmann, U. Weiland, J. Haendeler, and A. M. Zeiher. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res. 81: 970-976, 1997.
4. Fransen, L., R. Muller, A. Marmenout, J. Tavernier, J. Van der Heyden, E. Kawashima, A. Chollet, R. Tizard, H. Van Heuverswyn, A. Van Vliet, M. R. Ruysschaert, and W. Fiers. Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res. 13: 4417-4429, 1985.
5. Gray, P. W., D. Glaister, E. Chen, D. V. Goeddel, and D. Pennica. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1-β. J. Immunol. 137: 3644-3648, 1986.
6. Gray, P. W., and D. V. Goeddel. Cloning and expression of murine immune Interferon cDNA. Proc. Natl. Acad. Sci. USA 80: 5842-5846, 1983.
7. Grenett, H. E., N. L. Fuentes, and G. M. Fuller. Cloning and sequence analysis of the cDNA for murine interleukin-6. Nucleic Acids Res. 18: 6455, 1990.
8. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739, 1998.
9. Harada, H, M. Kitagawa, N. Tanaka, H. Yamamoto, K. Harada, M. Ishihara, and T. Taniguchi. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259: 971-974, 1993.
10. Haunstetter, A., and S. Izumo. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82: 1111-1129, 1998.
11. Hein, L., G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 377: 744-747, 1996.
12. Hirosumi, J., A. Nomoto, Y. Ohkubo, C. Sekiguchi, S. Mutoh, I. Yamaguchi, and H. Aoki. Inflammatory responses in cuff-induced atherosclerosis in rabbits. Atherosclerosis 64: 243-254, 1987.
13. Horiuchi, M., W. Hayashida, T. Kambe, T. Yamada, and V. J. Dzau. Angiotensin II type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272: 19022-19026, 1997.
14. Horiuchi, M., G. Koike, T. Yamada, M. Mukoyama, M. Nakajima, and V. J. Dzau. The growth dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2. J. Biol. Chem. 270: 20225-20230, 1995.
15. Horiuchi, M., T. Yamada, W. Hayashida, and V. J. Dzau. Interferon regulatory factor-1 upregulates angiotensin type 2 receptor and induces apoptosis. J. Biol. Chem. 272: 11952-11958, 1997.
16. Huckle, W. R., M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. Fujita, I. I. Stabilito, D. Kim, D. L. Ondeyka, N. B. Mantlo, R. S. Chang, C. F. Reilly, K. S. Schwartz, W. J. Greenlee, and R. G. Johnson, Jr. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation 93: 1009-1019, 1996.
17. Ichiki, T., P.A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. Hogan, and T. Inagami. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750, 1995.
18. Janiak, P., A. Pillon, J. F. Prost, and J. P. Vilaine. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20: 737-745, 1992.
19. Kambayashi, Y., S. Bardhan, K. Takahashi, S. Tsuzuki, H. Inui, T. Hamakubo, and T. Inagami. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268: 24543-24546, 1993.
20. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612-1615, 1994.
21. Kirchhoff, S., F. Schaper, and H. Hauser. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res. 21: 2881-2889, 1993.
22. Laflamme, L., M. Gasparo, J. M. Gallo, M. D. Payet, and N. Gallo-Payet. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J. Biol. Chem. 271: 22729-22735, 1996.
23. Mach, F., U. Schönbeck, G. K. Sukhova, E. Atkinson, and P. Libby. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394: 200-203, 1998.
24. Meffert, S., M. Stoll, U. M. Steckelings, S. P. Bottari, and T. Unger. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell. Endocrinol. 122: 59-67, 1996.
25. Mukoyama, M., M. Nakajima, M. Horiuchi, H. Sasamura, R. E. Pratt, and V. J. Dzau. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 268: 24539-24542, 1993.
26. Nakajima, M., H. Hutchinson, M. Fujinaga, W. Hayashida, R. Morishita, L. Zhang, M. Horiuchi, R. E. Pratt, and V. J. Dzau. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain of function study using in vivo gene transfer. Proc. Natl. Acad. Sci. USA 92: 10663-10667, 1995.
27. Nakajima, M., M. Mukoyama, R. E. Pratt, M. Horiuchi, and V. J. Dzau. Cloning of cDNA and analysis of the gene for mouse angiotensin type 2 receptor. Biochem. Biophys. Res. Commun. 197: 393-399, 1993.
28. Ozono, R., Z. Q. Wang, A. F. Moore, T. Inagami, H. M. Siragy, and R. M. Carey. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
29. Pollman, M. J., T. Yamada, M. Horiuchi, and G. H. Gibbons. Vasoactive substances regulate smooth muscle cell apoptosis: counteracting influences of nitric oxide and angiotensin II. Circ. Res. 179: 748-756, 1996.
30. Ridker, P. M., M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336: 973-979, 1997.
31. Ridker, P. M., C. H. Hennekens, B. Roitman-Johnson, M. J. Stampfer, and J. Allen. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351: 88-92, 1998.
32. Sabath, D. E., H. E. Broome, and M. B. Prystowsky. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 91: 185-191, 1990.
33. Sasamura, H., L. Hein, J. E. Krieger, R. E. Pratt, B. K. Kobilka, and V. J. Dzau. Cloning, characterization, and expression of two angiotensin receptor (AT1) isoforms from the mouse genome. Biochem. Biophys. Res. Commun. 185: 253-259, 1992.
34. Shanmugam, S., P. Corvol, and J. M. Gasc. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 28: 91-97, 1996.
35. Spink, J., and T. Evans. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 272: 24417-24425, 1997.
36. Stoll, M., M. Steckelings, M. Paul, S. P. Bottari, R. Metzger, and T. Unger. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95: 651-657, 1995.
37. Tamura, T., M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki, and T. Taniguchi. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599, 1995.
38. Tanaka, N., M. Ishihara, M. Kitagawa, H. Harada, T. Kimura, T. Matsuyama, M. S. Lamphier, S. Aizawa, T. W. Mak, and T. Taniguchi. Cellular commitment to oncogene induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839, 1994.
39. Tanaka, N., T. Kawakami, and T. Taniguchi. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13: 4531-4538, 1993.
40. Tilly, J. L., and A. J. Hsueh. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J. Cell Physiol. 154: 519-526, 1993.
41. Viswanathan, M., K. Tsutsumi, F. M. Correa, and J. M. Saavedra. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 179: 1361-1367, 1991.
42. Yamada, G., M. Ogawa, K. Akagi, H. Miyamoto, N. Nakano, S. Itoh, J. Miyazaki, S. Nishikawa, K. Yamamura, and T. Taniguchi. Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc. Natl. Acad. Sci. USA 88: 532-536, 1991.
43. Yamada, T., M. Akishita, M. J. Pollman, G. H. Gibbons, V. J. Dzau, and M. Horiuchi. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci. 63: 289-295, 1998.
44. Yamada, T., M. Horiuchi, and V. J. Dzau. The novel angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA 93: 156-160, 1996.